MARKET

APUS

APUS

Apimeds Pharmaceutical U.S, Inc.
AMEX
--
0.00
0.00%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
Preview: Apimeds Pharmaceuticals Us, Inc Set To IPO Tomorrow
Benzinga · 03/04 15:01
IPO Roundup: Kestra Medical Technologies, MNTN and more
Seeking Alpha · 03/03 13:45
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline
Seeking Alpha · 03/01 07:45
IPO Roundup: Advanced Biomed, Brag House Holdings and more
Seeking Alpha · 02/25 14:07
Apimeds Pharmaceuticals Us, Inc To Start Trading Tomorrow
Benzinga · 02/20 15:00
IPO Roundup: Anbio Biotechnology, Wellgistics Health and more
Seeking Alpha · 02/18 14:02
U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week
Seeking Alpha · 02/15 04:50
Catalyst Watch: Apple product event, Walmart earnings, Sandisk debut, and Visa's Investor Day
Seeking Alpha · 02/14 20:00
More
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.

Webull offers Apimeds Pharmaceuticals US, Inc. stock information, including AMEX: APUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APUS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APUS stock methods without spending real money on the virtual paper trading platform.